Inventor · disambiguated record
Stefan Offermanns
Also filed as: OFFERMANNS STEFAN
3 granted patents·7 pending applications·54 citations·filing 1997–2023
67Inventor score
Files withMAX PLANCK GESELLSCHAFT3AURORA BIOSCIENCES CORP1CALIFORNIA INST OF TECHN1INVITROGEN CORP A DELAWARE COR1MAX PLANCK GES ZUR FÖRDERUNG DER WISSENSCHAFTEN E V1
Top patents by PatentIndex Score
10 records- 0179US6004808APromiscuous G-protein compositions and their useAURORA BIOSCIENCES CORP·Filed 1997·Granted Dec 21, 1999·50 cites·27 claims
- 0264US9198966B2B-type plexin antagonists and uses thereofOFFERMANNS STEFAN·Filed 2012·Granted Dec 1, 2015·4 cites·11 claims
- 0358US2025388639A1Therapeutic applications based on the inhibition of G Protein-Coupled Receptor 182 (GPR182)MAX PLANCK GESELLSCHAFT·Filed 2023·Application pending·0 cites
- 0447US2006008855A1Promiscuous G-protein compositions and their useINVITROGEN CORP A DELAWARE COR·Filed 2005·Application pending·0 cites
- 0544US2022162616A1Dual inhibition of plexin-b1 and plexin-b2MAX PLANCK GESELLSCHAFT·Filed 2020·Application pending·0 cites
- 0644US2015037351A1Novel therapeutic target for the prevention of tumour metastasisMAX PLANCK GESELLSCHAFT·Filed 2013·Application pending·0 cites
- 0734US2015031622A1Rhogef12 is a therapeutic target for the treatment of heart failureMAX PLANCK GES ZUR FÖRDERUNG DER WISSENSCHAFTEN E V·Filed 2013·Application pending·0 cites
- 0832US2017226514A1Prevention of tumour metastasis by inhibition of necroptosisMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WSS E V·Filed 2015·Application pending·0 cites
- 0931US2016075752A1B-type plexin antagonists and uses thereofUNIV HEIDELBERG RUPRECHT KARLS·Filed 2015·Application pending·0 cites
- 1026US6028244ADefective platelet activation in Gαq deficient miceCALIFORNIA INST OF TECHN·Filed 1998·Granted Feb 22, 2000·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Stefan Offermanns files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →